With vinyl methyl oxazolidinone (VMOX), BASF offers a new vinyl monomer in commercial quantities.
VMOX is particularly suitable as a reactive diluent in UV curing inks and coatings, which can for example be used for digital UV printing.
In these applications, the vinyl monomer has many technical benefits compared to conventional reactive diluents and allows innovative coatings formulations with a favorable toxicological profile.
BASF will be presenting VMOX for the first time at the European Coatings Show, which will be held from March 19 to 21 in Nuremberg.
VMOX is liquid at room temperature and has a very low viscosity of ca. 4 mPas.
Compared to conventional raw materials, it enables the preparation of low-viscous and almost odourless formulations.
VMOX is characterised by a high copolymerisation reactivity with acrylates.
The monomer brings excellent adhesion properties on all common substrates, even at low dosages.
It also enables more brilliant colours in the final printed products and coatings.
The toxicological profile of VMOX is an additional benefit.
Compared to conventional products, according to the European Chemicals Agency (ECHA) classification, VMOX does not require the labels “serious health hazard” and “acute toxicity”.
The product is fully REACH registered up to 1000t.
With VMOX, BASF is adding to the industry’s most comprehensive portfolio of functional vinyl monomers, such as vinyl ethers and N-vinyl compounds.
These high-quality intermediates are commonly used for example in the production of coatings, adhesives, biocides, high-performance oils, flavourings and printing inks.
BASF combines 90 years of experience in the vinyl monomers research field with state-of-the-art technology, with manufacturing taking place in Europe.